News & media
Explore our press releases, clinical trial updates and employee stories.
Stay informed about Salvia's commitment to improving the lives of people with migraine.
News & media
Explore our press releases, clinical trial updates and employee stories.
Stay informed about Salvia's commitment to improving the lives of people with migraine.
Meet Brian, our technician
"I know how an implant can change your life, and I want others to experience the same impact.”
Meet Steve Gee, our Senior Electronics Engineer
“I design electronics not only out of personal passion, but primarily because I want to make a meaningful impact on people's lives.”
.jpg)
Salvia awarded €5.1M funding from European Innovation Council
Today, the European Innovation Council (EIC) announced Salvia was awarded a €5.1M blended funding award from EIC’s accelerator program for the clinical development of a complementary chronic cluster headache indication for its innovative neuromodulation system.
Meet Shriya Rangaswamy, our Process Development Engineer
"Thanks to the female role models at Salvia, I also saw opportunities for my own professional and personal growth.”
.jpg)
Meet Joep, our Software Developer
"The fact that I can contribute to something with a real impact was the deciding factor for me to work here.”
Meet Maïlys, our Senior Biomedical Engineer
"My mom helps people with migraine, and that's really important," says Mailys Guillard's 9-year-old daughter, describing her mother, who has been a part of the Salvia team since the beginning.
Salvia BioElectronics Appoints Jan Pieter Heemels as Chief Commercial Officer
As CCO, Heemels will be a member of Salvia’s executive team and will drive the company’s market access and commercialization efforts.
.jpg)
Belgian patients first in Europe to receive pioneering implant for migraine
AZ Delta in Roeselare has successfully treated its first patients for severe migraine with a paper-thin implant. This is the second time worldwide and the first time in Europe that the bioelectronic foil, developed by Dutch start-up Salvia BioElectronics, has been implanted.
.jpg)
First patient receiving groundbreaking solution for migraine and cluster headache
Salvia BioElectronics, a pioneering Dutch company focused on neuromodulation for migraine and cluster headache, today announced the successful first implantation of their paper-thin neuromodulation solution.
Salvia BioElectronics Appoints Former MedTech Investor Jeroen Siemes as Chief Financial Officer
Salvia BioElectronics has appointed Jeroen Siemes as its new Chief Financial Officer (CFO), adding a seasoned finance and investment expert to the team.
Meet Maartje, our Senior Process Development Engineer
With a background in chemical technology and material science, Maartje brings her expertise to the forefront of innovative medical technology.
Meet Stijn, our Product Architect
"As a medical device engineer, experiencing the entire product development process and seeing the first successful outcomes in the clinic is a rare and fulfilling event in one's career."
Meet Liz, our Document Specialist
For Liz, one principle stands above all: daring to be yourself. Something she picked up during her many travels and living in various countries.
Meet Pete, our Principal Field Clinical Scientist
Throughout his career, Pete has had the privilege of working with a number of exciting healthcare companies. It was in these professional environments that he first encountered the profound impact of neuromodulation.
Meet Kambiz, our Senior Reliability Engineer
Kambiz has been immersed in the field of neuromodulation for a decade. Before joining Salvia, he had the chance to work at Sapiens, a "very bold" startup he admired, via a program of the Eindhoven University of Technology.
Salvia Insights
Starting in mid-2024, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?
We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.